Tag

Lantidra

All articles tagged with #lantidra

health2 years ago•4 min saved

"Breakthrough: US Now Offers Functional Cure for Diabetes"

The FDA has approved Lantidra, a treatment for brittle diabetes developed by Chicago startup CellTrans. Lantidra contains insulin-secreting cells sourced from donated pancreases, which, when transplanted into a person with diabetes, can minimize or eliminate the need for synthetic insulin. Islet transplantation, the technique used in Lantidra, has been considered experimental in the US but has been approved and covered by insurance in other countries. While Lantidra has shown promising results, it does come with risks, including the need for immunosuppressant drugs and potential adverse reactions. However, an advanced version of the therapy using stem cells is currently in development and could potentially make islet transplantation more widely accessible, offering a functional cure for diabetes.

via Freethink|

#diabetes #fda #health

health2 years ago•7 min saved

Cell therapy breakthrough: Less insulin needed for type 1 diabetes

The FDA has approved Lantidra, the first cellular therapy for type 1 diabetes. Lantidra is an allogeneic pancreatic islet cellular therapy made from deceased donor pancreatic cells. Clinical studies have shown that some participants who received Lantidra did not need to administer insulin for more than 5 years. This therapy is intended for individuals with type 1 diabetes who struggle to control their blood sugar levels despite intensive management. However, Lantidra does come with potential side effects and requires the use of immunosuppressive medications. While this approval is a significant step towards alternative therapies for type 1 diabetes, it is not suitable for all patients due to its side effect profile and the need for ongoing immunosuppression.

via Medical News Today|

#cellular-therapy #fda #health

health2 years ago•4 min saved

"Groundbreaking FDA Approval: First-Ever Cell Therapy for Type 1 Diabetes"

CellTrans, a small biotech company, has become the first to receive FDA approval for a cell therapy, known as Lantidra, for the treatment of type 1 diabetes. Lantidra, administered via an infusion into the liver, aims to provide insulin independence for adults with type 1 diabetes who struggle to achieve target glucose levels. The therapy is made from pancreatic cells sourced from deceased donors and requires the use of immunosuppressive drugs. While some patients have experienced insulin independence for several years, there are risks associated with chronic immunosuppression. Other companies, such as Vertex Pharmaceuticals and Eli Lilly, are also developing cell therapies for type 1 diabetes.

via MedCity News|

#cell-therapy #fda-approval #health

health2 years ago•2 min saved

FDA Approves Groundbreaking Cell Therapy for Type 1 Diabetes

The FDA has approved Lantidra, a cellular therapy made from deceased donor pancreatic cells, to help adults with Type 1 diabetes maintain their target blood glucose levels. Lantidra aims to replace the insulin-producing beta cells in the pancreas, potentially eliminating the need for daily injections or infusions of insulin. Clinical studies have shown that a significant number of participants did not need insulin for one to five years or more after receiving Lantidra infusions. However, there were some side effects and serious adverse reactions reported, so patients are advised to discuss the benefits and risks with their doctors.

via WXYZ 7 Action News Detroit|

#cellular-therapy #fda #health

healthcare2 years ago•0 min saved

FDA Approves Revolutionary Cell Therapy for Type 1 Diabetes

The FDA has granted approval to Chicago-based CellTrans for its pancreatic islet cell therapy, known as Lantidra or donislecel, making it the first-ever cell therapy treatment option for certain patients with type 1 diabetes who struggle to maintain normal blood glucose levels despite intensive management. The therapy utilizes pancreatic cells from deceased donors.

via Endpoints News|

#cell-therapy #fda #healthcare

health2 years ago•3 min saved

Breakthrough: FDA Approves Revolutionary Cellular Therapy for Type 1 Diabetes

The FDA has approved Lantidra, the first cellular therapy for the treatment of type 1 diabetes. Lantidra is made from deceased donor pancreatic cells and is intended for adults with type 1 diabetes who experience severe hypoglycemia despite intensive diabetes management. The therapy works by infusing allogeneic islet beta cells, which can produce enough insulin to potentially eliminate the need for daily insulin injections. However, adverse reactions such as nausea, fatigue, and abdominal pain were observed, and some patients had to discontinue immunosuppressive medications, resulting in the loss of islet cell function.

via FDA.gov|

#cellular-therapy #fda #health